Abstract:Objectives Previous studies have suggested that blood values of carotenoids may be inversely associated with various chronic diseases, but limited data are available in Asian populations. This study examined the associations of serum carotenoids with metabolic sysndrome (MS), non‐alcoholic fatty liver disease (NAFLD), carotid intima‐media thickness (cIMT), bone mineral density (BMD) and skeletal muscle mass in adults. Methods In this community‐based study, we enrolled 4008 Chinese aged between 40–75 years in Guangzhou, China in 2011–2013. We completed the measurements of overnight fasting serum carotenoids of α‐carotene, β‐carotene, β‐cryptoxanthin, Lutein+zeaxanthin, total of them using a HPLC method, cIMT at the common carotid artery (CCA) and at the bifurcation (BIF) and presence and degree of NAFLD by B‐mode ultrasound, serum lipids, glucose, blood pressure and body measurements, and BMD at the whole body (WB), lumbar spine (LS) and hip (total and neck), and skeletal muscle mass at the limbs using a dual energy x‐ray absorptiometry in about 3000 subjects. Covariates were collected using interviewer‐adminstrated structured questionnaires. Up to date, 1628 subjects had completed the follow‐up measurements of the above outcome variables after a mean interval of 3.1 years (lost rate: 22%). Results In the cross‐sectional analyses after adjusted for multiple covariates, the odds ratios (95%CI) for the individual carotenoids (quartile 4 vs. 1) were ranged between 0·23 (0·15, 0·36) (β‐carotene) to 0·44 0·29, 0·67 (lycopene) for the presence of MS (all p‐trend<0.01), and between 0.32 (0.25,0.41) (β‐carotene) to 0.62 (0.49,0.79) (β‐cryptoxanthin) for the presence of NAFLD (all p‐trend<0.01). The values of IMT in quartie 4 (vs. 1) were lower by 4.16%–5.12% and 2.69%–5.63% for all carotenoids (p‐trend: <0.001), except for lycopene (2.09% & 1.19%) at the CCA and BIF. Greater levels of α‐carotene, β‐carotene, and β‐cryptoxanthin were significantly associated with higher BMD values (difference for quartile 4 vs. 1: 1.5%–4.0%). All carotenoids (except β‐cryptoxanthin) had significant and favorable associations with skeletal muscle mass index (SMI, total muscle mass/height 2 , kg/m 2 ). The percent differences for quartile 4 (vs. 1) were 1.77%–2.34%. In the follow‐up analyses, the favorable associations of the carotenoids with the changes in IMT, the severity of NAFLD, BMD and SMI were less significant possibly due to smaller number of subjects followed‐up at present, although similar trends were observed to those in the cross‐sectional results. Conclusions Greater concentrations of serum carotenoids was associated with lower presenc of MS and NAFLD, lower values of cIMT, and higher levels of BMD and skeletal muscle mass, and might be benefit to their changes in middle‐aged and elderly adults. Support or Funding Information The study was jointly supported by the National Natural Science Foundation of China (no. 81472965, 81273049, 81130052) and the 5010 Program for Clinical Researches (No. 2007032) by the Sun Yat‐sen University, Guangzhou, China

Circulating carotenoids are associated with favorable lipid and fatty acid profiles in an older population at high cardiovascular risk

Aging and antioxidants: the impact of dietary carotenoid intakes on soluble klotho levels in aged adults

Long-Term Intake of Dietary Carotenoids is Positively Associated with Late-Life Subjective Cognitive Function in a Prospective Study in US Women

Carotenoids: potential allies of cardiovascular health?

Plasma Lipidomic Profiles and Cardiovascular Events in a Randomized Intervention Trial with the Mediterranean Diet.

Plasma Lipidome Patterns Associated with Cardiovascular Risk in the PREDIMED Trial: A Case-Cohort Study

Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions.

Metabolomic Profiles of Plasma Retinol-Associated Dyslipidemia in Men and Women.

Higher Serum Carotenoid Concentration Associated with A Lower Incidence of Metabolic Syndrome in Middle-Aged and Elderly Chinese Adults

Carotenoid pattern intake and relation to metabolic status, risk and syndrome, and its components – divergent findings from the ORISCAV-LUX-2 survey

Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.

Pro-vegetarian food patterns and cardiometabolic risk in the PREDIMED-Plus study: a cross-sectional baseline analysis

Total and Subtypes of Dietary Fat Intake and Its Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiovascular Risk

Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study

Associations of Serum Carotenoids with Metabolic-Related Diseases in Middle-Aged and Elderly Adults: A Cross-Sectional and Follow-Up Study

Relationship of serum carotenoid concentrations with allostatic load as a measure of chronic stress among middle-aged adults in the USA

Dietary antioxidant intake reduces carotid intima-media thickness in coronary heart disease patients: From the CORDIOPREV study

Lack of a Synergistic Effect on Cardiometabolic and Redox Markers in a Dietary Supplementation with Anthocyanins and Xanthophylls in Postmenopausal Women

Associations of Serum Carotenoids with DXA-Derived Body Fat and Fat Distribution in Chinese Adults: A Prospective Study

Assessing the Impact of (Poly)phenol-Rich Foods on Cardiometabolic Risk in Postmenopausal Women: A Dietary Trial